Peterson Wealth Services grew its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.0% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,418 shares of the healthcare conglomerate’s stock after buying an additional 87 shares during the period. Peterson Wealth Services’ holdings in UnitedHealth Group were worth $1,378,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in UNH. Citizens National Bank Trust Department grew its holdings in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after buying an additional 170 shares during the last quarter. Caitlin John LLC grew its stake in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 111 shares during the last quarter. Triumph Capital Management purchased a new position in shares of UnitedHealth Group in the second quarter worth about $1,324,000. Wealth Effects LLC boosted its position in UnitedHealth Group by 14.4% in the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after buying an additional 591 shares during the last quarter. Finally, Arlington Partners LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $2,229,000. 87.86% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
UNH has been the topic of a number of research reports. Truist Financial increased their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Mizuho lifted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Barclays raised their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price on the stock. Finally, Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $385.13.
UnitedHealth Group Trading Up 0.6%
UNH stock opened at $362.78 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a market cap of $328.56 billion, a price-to-earnings ratio of 15.72, a PEG ratio of 2.33 and a beta of 0.47. The business’s 50-day moving average is $338.43 and its 200 day moving average is $338.97.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio is 38.30%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- 3 Monster Growth Stocks to Buy Now
- MarketBeat Week in Review – 10/20 – 10/24
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to Effectively Use the MarketBeat Ratings Screener
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
